Meitav Dash Investments LTD Gilead Sciences, Inc. Transaction History

Meitav Dash Investments LTD

$5.8 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$76.01 - $86.7 $335,128 - $382,260	4,409 New	4,409 $339,000
Q1 2023 May 11, 2023	SELL	$77.31 - $88.08 $115,810 - $131,943	-1,498 Reduced 32.86%	3,061 $253,000
Q3 2022 Oct 31, 2022	BUY	$59.54 - $68.01 $271,442 - $310,057	4,559 New	4,559 $287,000
Q1 2022 May 09, 2022	SELL	$57.92 - $72.58 $235,213 - $294,747	-4,061 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$64.88 - $73.64 $291,960 - $331,380	-4,500 Reduced 52.56%	4,061 $297,000
Q3 2021 Nov 03, 2021	SELL	$67.69 - $73.03 $33,845 - $36,515	-500 Reduced 5.52%	8,561 $603,000
Q2 2021 Aug 05, 2021	BUY	$63.47 - $69.35 $317,350 - $346,750	5,000 Added 123.12%	9,061 $619,000
Q1 2021 May 06, 2021	SELL	$60.0 - $68.46 $132,000 - $150,612	-2,200 Reduced 35.14%	4,061 $263,000
Q4 2020 Feb 02, 2021	SELL	$56.65 - $64.55 $181,280 - $206,560	-3,200 Reduced 33.82%	6,261 $361,000
Q3 2020 Nov 05, 2020	BUY	$62.1 - $78.08 $186,300 - $234,240	3,000 Added 46.43%	9,461 $593,000
Q2 2020 Aug 10, 2020	SELL	$72.34 - $84.0 $640,136 - $743,316	-8,849 Reduced 57.8%	6,461 $491,000
Q1 2020 May 11, 2020	BUY	$62.63 - $80.22 $623,794 - $798,991	9,960 Added 186.17%	15,310 $1.15 Million
Q4 2019 Feb 10, 2020	SELL	$61.62 - $67.78 $5,545 - $6,100	-90 Reduced 1.65%	5,350 $348,000
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $151,581 - $169,981	-2,450 Reduced 31.05%	5,440 $364,000
Q1 2019 May 13, 2019	BUY	$62.53 - $70.05 $18,321 - $20,524	293 Added 3.86%	7,890 $506,000
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $32,267 - $42,107	-533 Reduced 6.56%	7,597 $453,000
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $247,983 - $274,562	-3,479 Reduced 29.97%	8,130 $621,000
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $56,705 - $66,144	-874 Reduced 7.0%	11,609 $998,000
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $199,800 - $243,578	2,743 Added 28.16%	12,483 $939,000
Q4 2017 Feb 15, 2018	BUY	$71.15 - $83.52 $693,001 - $813,484	9,740	9,740 $704,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meitav Dash Investments LTD, based on Form 13F filings with the SEC.

News

Stay updated on Meitav Dash Investments LTD with notifications on news.

Account